Pediatric rhabdomyosarcoma of the head and neck

M. Boyd Gillespie, David T. Marshall, Terry A. Day, Allen O. Mitchell, David R. White, Julio Barredo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Pediatric rhabdomyosarcoma is not exclusive to the head and neck. However, the unique anatomy of the head and neck requires special consideration and treatment modifications. The low incidence of these tumors has prevented the development of rigorous treatment protocols. Treatment strategies must be individualized on the basis of histopathologic subtype, prognostic indicators, tumor location, tumor extent, available clinical trial data, and hospital resources. The primary treatment of these tumors typically involves a combination of surgery, radiation, and chemotherapy. Advancements in surgical and radiotherapy techniques have reduced patient morbidity, whereas new chemotherapeutic protocols have improved local disease control and overall survival. Because of the infrequency and complexity of these tumors, patients may benefit from referral to centers with a comprehensive multidisciplinary team that has experience treating these tumors in the pediatric population. If possible, patients should be enrolled and treated on the current Children's Oncology Group protocol.

Original languageEnglish
Pages (from-to)13-22
Number of pages10
JournalCurrent Treatment Options in Oncology
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Rhabdomyosarcoma
Neck
Head
Pediatrics
Neoplasms
Clinical Protocols
Anatomy
Radiotherapy
Therapeutics
Referral and Consultation
Clinical Trials
Radiation
Morbidity
Drug Therapy
Survival
Incidence
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gillespie, M. B., Marshall, D. T., Day, T. A., Mitchell, A. O., White, D. R., & Barredo, J. (2006). Pediatric rhabdomyosarcoma of the head and neck. Current Treatment Options in Oncology, 7(1), 13-22. https://doi.org/10.1007/s11864-006-0028-3

Pediatric rhabdomyosarcoma of the head and neck. / Gillespie, M. Boyd; Marshall, David T.; Day, Terry A.; Mitchell, Allen O.; White, David R.; Barredo, Julio.

In: Current Treatment Options in Oncology, Vol. 7, No. 1, 01.01.2006, p. 13-22.

Research output: Contribution to journalArticle

Gillespie, MB, Marshall, DT, Day, TA, Mitchell, AO, White, DR & Barredo, J 2006, 'Pediatric rhabdomyosarcoma of the head and neck', Current Treatment Options in Oncology, vol. 7, no. 1, pp. 13-22. https://doi.org/10.1007/s11864-006-0028-3
Gillespie, M. Boyd ; Marshall, David T. ; Day, Terry A. ; Mitchell, Allen O. ; White, David R. ; Barredo, Julio. / Pediatric rhabdomyosarcoma of the head and neck. In: Current Treatment Options in Oncology. 2006 ; Vol. 7, No. 1. pp. 13-22.
@article{c873217e3ea049599431f6de95cbcb49,
title = "Pediatric rhabdomyosarcoma of the head and neck",
abstract = "Pediatric rhabdomyosarcoma is not exclusive to the head and neck. However, the unique anatomy of the head and neck requires special consideration and treatment modifications. The low incidence of these tumors has prevented the development of rigorous treatment protocols. Treatment strategies must be individualized on the basis of histopathologic subtype, prognostic indicators, tumor location, tumor extent, available clinical trial data, and hospital resources. The primary treatment of these tumors typically involves a combination of surgery, radiation, and chemotherapy. Advancements in surgical and radiotherapy techniques have reduced patient morbidity, whereas new chemotherapeutic protocols have improved local disease control and overall survival. Because of the infrequency and complexity of these tumors, patients may benefit from referral to centers with a comprehensive multidisciplinary team that has experience treating these tumors in the pediatric population. If possible, patients should be enrolled and treated on the current Children's Oncology Group protocol.",
author = "Gillespie, {M. Boyd} and Marshall, {David T.} and Day, {Terry A.} and Mitchell, {Allen O.} and White, {David R.} and Julio Barredo",
year = "2006",
month = "1",
day = "1",
doi = "10.1007/s11864-006-0028-3",
language = "English",
volume = "7",
pages = "13--22",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Pediatric rhabdomyosarcoma of the head and neck

AU - Gillespie, M. Boyd

AU - Marshall, David T.

AU - Day, Terry A.

AU - Mitchell, Allen O.

AU - White, David R.

AU - Barredo, Julio

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Pediatric rhabdomyosarcoma is not exclusive to the head and neck. However, the unique anatomy of the head and neck requires special consideration and treatment modifications. The low incidence of these tumors has prevented the development of rigorous treatment protocols. Treatment strategies must be individualized on the basis of histopathologic subtype, prognostic indicators, tumor location, tumor extent, available clinical trial data, and hospital resources. The primary treatment of these tumors typically involves a combination of surgery, radiation, and chemotherapy. Advancements in surgical and radiotherapy techniques have reduced patient morbidity, whereas new chemotherapeutic protocols have improved local disease control and overall survival. Because of the infrequency and complexity of these tumors, patients may benefit from referral to centers with a comprehensive multidisciplinary team that has experience treating these tumors in the pediatric population. If possible, patients should be enrolled and treated on the current Children's Oncology Group protocol.

AB - Pediatric rhabdomyosarcoma is not exclusive to the head and neck. However, the unique anatomy of the head and neck requires special consideration and treatment modifications. The low incidence of these tumors has prevented the development of rigorous treatment protocols. Treatment strategies must be individualized on the basis of histopathologic subtype, prognostic indicators, tumor location, tumor extent, available clinical trial data, and hospital resources. The primary treatment of these tumors typically involves a combination of surgery, radiation, and chemotherapy. Advancements in surgical and radiotherapy techniques have reduced patient morbidity, whereas new chemotherapeutic protocols have improved local disease control and overall survival. Because of the infrequency and complexity of these tumors, patients may benefit from referral to centers with a comprehensive multidisciplinary team that has experience treating these tumors in the pediatric population. If possible, patients should be enrolled and treated on the current Children's Oncology Group protocol.

UR - http://www.scopus.com/inward/record.url?scp=31344460054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344460054&partnerID=8YFLogxK

U2 - 10.1007/s11864-006-0028-3

DO - 10.1007/s11864-006-0028-3

M3 - Article

C2 - 16343365

AN - SCOPUS:31344460054

VL - 7

SP - 13

EP - 22

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 1

ER -